Preliminary Efficacy of a Community-Based Remote Cardiac Rehabilitation Program on Cardiopulmonary Function and Quality of Life in Pediatric Patients With Complex Congenital Heart Disease: A Single Blind, Randomized Controlled Trial
This study aims to evaluate the preliminary efficacy of a 12-week community-based remote cardiac rehabilitation program on cardiopulmonary function and quality of life in pediatric patients (aged 8 to 18 years) with complex congenital heart disease. Participants will be randomly assigned to either an experimental group receiving the remote cardiac rehabilitation program or a control group receiving the standard of care.
• Aged 8 to 18 years.
• Diagnosed with complex congenital heart disease (e.g., single ventricle, transposition of the great arteries) and have a history of cardiac surgery.
• At least 3 months post-cardiac surgery and maintaining a stable hemodynamic status.
• Capable of utilizing remote programs (mobile apps, video platforms, etc.) in the home environment with technical support from guardians.
• Participant or guardian has agreed to participate and signed the written informed consent form.
• Confirmed to have decreased physical activity level and physical well-being through assessments (Must meet both):
• KIDSCREEN-27 Parent Proxy-report 'Physical well-being' domain T-score of 40 or below.
• Exercise Vital Sign (EVS) survey indicating moderate-to-vigorous physical activity (MVPA) time of less than 420 minutes per week.